On the other hand, aggregates were absent or present to a very low extent in animals treated with antagonist LY 341495, which indicates that mGluR3 blockage inhibited GSC-dependent generation of tumor cell progeny and/or reduced the growth of GBM malignant cells. This evidence concerns the gene GRM3 and neoplasm.